decorative background image

Targeted ‘radioligand’ improves survival in advanced prostate cancer

cells

Cancer researchers say they have established a new, life-extending treatment option for men with prostate cancer that has spread and become resistant to hormone therapy. The injected treatment combines a targeting compound with a radioactive isotope to irradiate and kill cancer cells.

Read the full article here

Share